Leading the way to safer medication
 Crosscheck  Recommender

Acipimox

Description

Acipimox inhibits the release of fatty acids from adipose tissue and reduces the blood concentrations of very low density lipoproteins (VLDL or Pre-beta) and low density lipoproteins (LDL or beta) with a subsequent overall reduction in triglyceride and cholesterol levels.

ATC Classification

Code
Title
Category
C10AD06
Acipimox
C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AD Nicotinic acid and derivatives

Trade names

Trade name
Countries

Netherlands

Netherlands Singapore United Kingdom

Product Monographs

Monograph
Type
Country
OLBETAM Capsule
MPI, EU: SmPC
UK